We use cookies to ensure that we give you the best experience on our website. By continuing to browse this repository, you give consent for essential cookies to be used. You can read more about our Privacy and Cookie Policy.

Durham Research Online
You are in:

Management of Helicobacter pylori infection-the Maastricht IV/Florence Consensus Report.

Malfertheiner, P. and Megraud, F. and O'Morain, C.A. and Atherton, J. and Axon, A.T. and Bazzoli, F. and Gensini, G.F. and Gisbert, J.P. and Graham, D.Y. and Rokkas, T. and El-Omar, E.M. and Kuipers, E.J. and European Helicobacter Study Group., (2012) 'Management of Helicobacter pylori infection-the Maastricht IV/Florence Consensus Report.', Gut., 61 (5). pp. 646-664.


Management of Helicobacter pylori infection is evolving and in this 4th edition of the Maastricht consensus report aspects related to the clinical role of H pylori were looked at again in 2010. In the 4th Maastricht/Florence Consensus Conference 44 experts from 24 countries took active part and examined key clinical aspects in three subdivided workshops: (1) Indications and contraindications for diagnosis and treatment, focusing on dyspepsia, non-steroidal anti-inflammatory drugs or aspirin use, gastro-oesophageal reflux disease and extraintestinal manifestations of the infection. (2) Diagnostic tests and treatment of infection. (3) Prevention of gastric cancer and other complications. The results of the individual workshops were submitted to a final consensus voting to all participants. Recommendations are provided on the basis of the best current evidence and plausibility to guide doctors involved in the management of this infection associated with various clinical conditions.

Item Type:Article
Full text:Full text not available from this repository.
Publisher Web site:
Record Created:14 Jun 2012 12:50
Last Modified:14 Jun 2012 15:09

Social bookmarking: del.icio.usConnoteaBibSonomyCiteULikeFacebookTwitterExport: EndNote, Zotero | BibTex
Look up in GoogleScholar | Find in a UK Library